Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 31-39 of 39 (Search time: 0.004 seconds).
Issue DateTitleAuthor(s)
2021Final results of CA209-9JC: A phase II study of first-line nivolumab in patients with advanced cutaneous squamous cell carcinomaMUNHOZ, R. Ramella; CAMARGO, V. P. de; MARTA, G. Nader; QUEIROZ, M. M.; CURY-MARTINS, J.; NARDO, M.; CHAUL-BARBOSA, C.; RICCI, H.; MATTOS, M. R. de; MENEZES, T. A. F. de; MACHADO, G. U. D. C.; BERTOLLI, E.; BARROS, M.; FRANKE, F. A.; FERREIRA, F. D. O.; FEHER, O.; CASTRO JR., G. de
2014LIVING BETTER OR LIVING LONGER? PERCEPTIONS OF PATIENTS (PTS) AND HEALTH CARE PROFESSIONALS (HCP) IN ONCOLOGYTOLOI, D. A.; CRITCHI, G.; MANGABEIRA, A.; HOFF, P. M.; MATSUSHITA, F.; SAAD, E. D.; RIECHELMANN, R. P.
2020ON-TRK: A non-interventional study of larotrectinib in patients with TRK fusion cancerLEYVRAZ, S.; YANG, J. C-H.; CASALI, P. G.; CASTRO, G.; KIM, E. S.; LASSEN, U. N.; LOPEZ-RIOS, F.; PENAULT-LLORCA, F.; PAPPO, A.; RUDZINSKI, E. R.; TABATABAI, G.; VASSAL, G.; REEVES, J. A.; NOGAI, H.; FELLOUS, M.; DRILON, A.; BROSE, M. S.; TRENT, J.
2020A randomized, open-label, parallel-design phase III study to compare adjuvant 5-FU plus oxaliplatin (mFLOX) versus observation in locally advanced rectal cancer after neoadjuvant chemoradiationBRAGHIROLI, M. I.; MONIZ, C. M. V.; RIECHELMANN, R. S. P.; DORNELLAS, A. F. L.; CAPARELLI, F.; ALBAN, L.; ALEX, A.; BARIANI, G. M.; LEITE, L. A. Senna; RIVELLI, T. Giollo; NEBULONI, D.; ORTEGA, C.; BRAGHIROLI, O. F. M.; MOUTINHO, K.; NAHAS, S.; NAHAS, C.; COTTI, G.; SABBAGA, J.; CECONELLO, I.; HOFF, P. M.
2022HIV impact in localized anal carcinoma: A matched cohort studyALMEIDA, A. Acioli De; ROCHA, E.; BONADIO, R. Colombo; GALHERA, D.; BRAGHIROLI, M. I.; ALBAN, L. B.; VICTOR, C. R.; DORNELLAS, A. F. L.; SILVA, M. Polo Mingueti E; CARVALHO, C. S. Araujo De; BUENO, A.; NAHAS, C.; IBRAHIM, K.; CHEN, A.; HOFF, P. M.; MONIZ, C. Motta Venchiarutti
2022Pembrolizumab (pembro) plus carboplatin (carbo) plus paclitaxel (pacli) as first-line (1L) therapy in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Phase VI KEYNOTE-B10 studyDZIENIS, M. R.; CUNDOM, J. E.; FUENTES, C. S.; HANSEN, A. R.; NORDLINGER, M. J.; PASTOR, A. V.; OPPELT, P.; NEKI, A.; GREGG, R. W.; LIMA, I. P. F.; FRANKE, F. A.; CUNHA JUNIOR, G. F. Da; TSENG, J. E.; LOREE, T.; JOSHI, A. J.; MCCARTHY, J. S.; NAICKER, N.; SIDI, Y.; GUMUSCU, B.; CASTRO JR., G. De
2022Pembrolizumab with or without chemotherapy for first-line treatment of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): 5-year results from KEYNOTE-048TAHARA, M.; GREIL, R.; RISCHIN, D.; HARRINGTON, K. J.; BURTNESS, B.; CASTRO JR., G. De; PSYRRI, A.; BRANA, I.; NEUPANE, P.; BRATLAND, A.; FUEREDER, T.; HUGHES, B. G. M.; NIN, R. Mesia; NGAMPHAIBOON, N.; RORDORF, T.; ISHAK, W. Z. Wan; LIN, J.; GUMUSCU, B.; LERMAN, N.; SOULIERES, D.
2022Predictors of in-hospital mortality after unplanned admissions among adults with cancer aged 80 years and olderNETO, F. Lazar; HIDALGO FILHO, C. M. T.; ROCHA, J. W. D.; SOBOTTKA, V. P.; STANGLER, L. T. B.; BENFATTI, G.; GUEDES, H.; CLARO, M. Z.; BONADIO, R. C.; DIZ, M. D. P. E.; HOFF, P. M.
2022Causes of unplanned hospitalizations and factors associated with in-hospital mortality among patients receiving chemotherapy treatmentHIDALGO FILHO, C. M. T.; LAZAR NETO, F.; ROCHA, J. W. D.; SOBOTTKA, V. P.; STANGLER, L. T. B.; BENFATTI, G.; GUEDES, H.; CLARO, M. Z.; BONADIO, R. C.; DIZ, M. D. P. E.; HOFF, P. M.